


Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 26 Jun 2006
Enrollment in Phase III Clinical Trial for OMRIX's Thrombin Stand-Alone Product Has Been Completed
Enrollment in Phase III Clinical Trial for OMRIX's Thrombin Stand-Alone Product Has Been Completed
HSMN NewsFeed - 26 Jun 2006
Cephalon Announces Results from GABITRIL(R) Clinical Program in Generalized Anxiety Disorder
Cephalon Announces Results from GABITRIL(R) Clinical Program in Generalized Anxiety Disorder
HSMN NewsFeed - 26 Jun 2006
Exelixis Appoints Experienced Biotechnology Executive as Chief Medical Officer
Exelixis Appoints Experienced Biotechnology Executive as Chief Medical Officer
HSMN NewsFeed - 26 Jun 2006
Wythe Therapeutics and VeroScience Announce Worldwide License for Cycloset(R)
Wythe Therapeutics and VeroScience Announce Worldwide License for Cycloset(R)
HSMN NewsFeed - 26 Jun 2006
Celator Pharmaceuticals Appoints Industry Veteran Felix Botelho as Head of Commercial Development
Celator Pharmaceuticals Appoints Industry Veteran Felix Botelho as Head of Commercial Development
HSMN NewsFeed - 26 Jun 2006
Data Safety Monitoring Board Recommends Continuation of ADVENTRX Phase IIb Clinical Trial for CoFactor
Data Safety Monitoring Board Recommends Continuation of ADVENTRX Phase IIb Clinical Trial for CoFactor
HSMN NewsFeed - 26 Jun 2006
NexMed Announces Termination of Alprox-TD Agreement With Schering AG and Provides Operational Update
NexMed Announces Termination of Alprox-TD Agreement With Schering AG and Provides Operational Update
HSMN NewsFeed - 26 Jun 2006
Vasogen Announces Initial Results from Phase III ACCLAIM Trial in Chronic Heart Failure
Vasogen Announces Initial Results from Phase III ACCLAIM Trial in Chronic Heart Failure
HSMN NewsFeed - 26 Jun 2006
Critical Therapeutics Announces Changes to Management Team and Board of Directors
Critical Therapeutics Announces Changes to Management Team and Board of Directors
HSMN NewsFeed - 26 Jun 2006
Pfizer Reaches Agreement to Sell Its Consumer Healthcare Business to Johnson & Johnson for $16.6 Billion
Pfizer Reaches Agreement to Sell Its Consumer Healthcare Business to Johnson & Johnson for $16.6 Billion
HSMN NewsFeed - 26 Jun 2006
BioAlliance Pharma Strengthens Operational Management Ahead of Loramyc(R) Launch
BioAlliance Pharma Strengthens Operational Management Ahead of Loramyc(R) Launch
HSMN NewsFeed - 23 Jun 2006
Ranbaxy Receives FDA Approval to Market Simvastatin 80mg Tablets with 180-Day Exclusivity
Ranbaxy Receives FDA Approval to Market Simvastatin 80mg Tablets with 180-Day Exclusivity
HSMN NewsFeed - 23 Jun 2006
Dr. Reddy's launches authorized generic versions of Proscar(R) and Zocor(R)
Dr. Reddy's launches authorized generic versions of Proscar(R) and Zocor(R)
HSMN NewsFeed - 23 Jun 2006
Penwest Announces That Endo Reports Receiving Final FDA Approval for Oxymorphone ER
Penwest Announces That Endo Reports Receiving Final FDA Approval for Oxymorphone ER
HSMN NewsFeed - 23 Jun 2006
Teva Announces Novartis' Sandoz Unit Seeks to Delay First FDA Approval of Generic Zocor(R)
Teva Announces Novartis' Sandoz Unit Seeks to Delay First FDA Approval of Generic Zocor(R)
HSMN NewsFeed - 22 Jun 2006
Court of Appeals Rules in Favor of Teva on Biaxin(R) XL Preliminary Injunction
Court of Appeals Rules in Favor of Teva on Biaxin(R) XL Preliminary Injunction
HSMN NewsFeed - 22 Jun 2006
NeoPharm Announces Appointment of Vice-President of Regulatory Affairs and Quality Assurance
NeoPharm Announces Appointment of Vice-President of Regulatory Affairs and Quality Assurance
HSMN NewsFeed - 22 Jun 2006
Sirion Therapeutics Acquires U.S. License to Develop New Treatment for Eye Disease
Sirion Therapeutics Acquires U.S. License to Develop New Treatment for Eye Disease
HSMN NewsFeed - 22 Jun 2006
Adams Respiratory Therapeutics Announces Resignation of Andrew N. Schiff, M.D. from Board of Directors
Adams Respiratory Therapeutics Announces Resignation of Andrew N. Schiff, M.D. from Board of Directors
HSMN NewsFeed - 21 Jun 2006
DUSA Pharmaceuticals Announces Georgia Court Dismissal of River's Edge Suit
DUSA Pharmaceuticals Announces Georgia Court Dismissal of River's Edge Suit
HSMN NewsFeed - 21 Jun 2006
First AdNectin Therapeutic, CT-322, Clears FDA IND Review to Start Clinical Trials
First AdNectin Therapeutic, CT-322, Clears FDA IND Review to Start Clinical Trials
HSMN NewsFeed - 2 Jun 2006
Introgen's ADVEXIN p53 Therapy Demonstrates Clinical Benefit in Inherited Cancer
Introgen's ADVEXIN p53 Therapy Demonstrates Clinical Benefit in Inherited Cancer
HSMN NewsFeed - 1 Jun 2006
Dr. Gabor Rubanyi of Berlex Biosciences Joins Cardium as Chief Scientific Officer
Dr. Gabor Rubanyi of Berlex Biosciences Joins Cardium as Chief Scientific Officer
HSMN NewsFeed - 1 Jun 2006
Cell Therapeutics, Inc. (CTI) and FDA Agree on NDA Filing Strategy for XYOTAX(TM)
Cell Therapeutics, Inc. (CTI) and FDA Agree on NDA Filing Strategy for XYOTAX(TM)
HSMN NewsFeed - 1 Jun 2006
Acuity Pharmaceuticals Reports Positive Initial Phase II Results for Bevasiranib (Cand5) in Wet AMD
Acuity Pharmaceuticals Reports Positive Initial Phase II Results for Bevasiranib (Cand5) in Wet AMD
HSMN NewsFeed - 1 Jun 2006
Advancis Pharmaceutical Completes Enrollment in Amoxicillin PULSYS Phase III Trial
Advancis Pharmaceutical Completes Enrollment in Amoxicillin PULSYS Phase III Trial
HSMN NewsFeed - 1 Jun 2006
Ablynx Strengthens Management Team - Eva-Lotta Allan Joins as Chief Business Officer
Ablynx Strengthens Management Team - Eva-Lotta Allan Joins as Chief Business Officer
HSMN NewsFeed - 31 May 2006
Archemix Corp. Strengthens its Board of Directors Adding Alnylam President and CEO, John Maraganore, Ph.D.
Archemix Corp. Strengthens its Board of Directors Adding Alnylam President and CEO, John Maraganore, Ph.D.
HSMN NewsFeed - 31 May 2006
Advanced Viral Research (ADVR) Names Abbott Veteran Angelo S. Botter to its Board of Directors
Advanced Viral Research (ADVR) Names Abbott Veteran Angelo S. Botter to its Board of Directors
HSMN NewsFeed - 31 May 2006
Adolor's Complete Response to Approvable Letter for Entereg(R) (Alvimopan) in POI Accepted for Review by FDA
Adolor's Complete Response to Approvable Letter for Entereg(R) (Alvimopan) in POI Accepted for Review by FDA
HSMN NewsFeed - 31 May 2006
Regeneron Receives Fast-Track Designation for the IL-1 Trap in CIAS1-Associated Periodic Syndromes (CAPS)
Regeneron Receives Fast-Track Designation for the IL-1 Trap in CIAS1-Associated Periodic Syndromes (CAPS)
HSMN NewsFeed - 31 May 2006
Vion Pharmaceuticals Provides Update for Clinical and Preclinical Programs
Vion Pharmaceuticals Provides Update for Clinical and Preclinical Programs
HSMN NewsFeed - 30 May 2006
Stiefel Laboratories Appoints Jim Loerop, Vice President U.S. Corporate Development
Stiefel Laboratories Appoints Jim Loerop, Vice President U.S. Corporate Development
HSMN NewsFeed - 30 May 2006
Stiefel Laboratories Appoints Alfonso Ugarte, Vice President Global Marketing
Stiefel Laboratories Appoints Alfonso Ugarte, Vice President Global Marketing
HSMN NewsFeed - 30 May 2006
PAREXEL International Appoints Douglas A. Batt as Senior Vice President and General Counsel
PAREXEL International Appoints Douglas A. Batt as Senior Vice President and General Counsel
HSMN NewsFeed - 30 May 2006
Oral Compound BG-12 Achieves Primary Endpoint in Phase II Study of Relapsing-Remitting Multiple Sclerosis
Oral Compound BG-12 Achieves Primary Endpoint in Phase II Study of Relapsing-Remitting Multiple Sclerosis
HSMN NewsFeed - 30 May 2006
Par Pharmaceutical Receives Final Approval to Market Polyethylene Glycol 3350 for Oral Solution
Par Pharmaceutical Receives Final Approval to Market Polyethylene Glycol 3350 for Oral Solution
HSMN NewsFeed - 30 May 2006
Corgentech Announces Appointment of Susan Kramer as Vice President of Preclinical Development
Corgentech Announces Appointment of Susan Kramer as Vice President of Preclinical Development
HSMN NewsFeed - 30 May 2006
Novelos Therapeutics Finalizes SPA with FDA for Phase 3 Trial in Lung Cancer
Novelos Therapeutics Finalizes SPA with FDA for Phase 3 Trial in Lung Cancer
HSMN NewsFeed - 26 May 2006
Introgen to Announce Important New Clinical Data for ADVEXIN Cancer Therapy at Major Medical Meetings
Introgen to Announce Important New Clinical Data for ADVEXIN Cancer Therapy at Major Medical Meetings
HSMN NewsFeed - 26 May 2006
FDA Approves ZOSTAVAX(R), Merck's New Vaccine for Prevention of Shingles in Adults Age 60 and Older
FDA Approves ZOSTAVAX(R), Merck's New Vaccine for Prevention of Shingles in Adults Age 60 and Older
HSMN NewsFeed - 26 May 2006
MGI PHARMA Announces Commercial Availability of Dacogen(TM) (Decitabine) for Injection
MGI PHARMA Announces Commercial Availability of Dacogen(TM) (Decitabine) for Injection
HSMN NewsFeed - 26 May 2006
FDA Advisory Committee to Consider Navy's Proposed 'RESUS' Trauma Trial at July 2006 Meeting
FDA Advisory Committee to Consider Navy's Proposed 'RESUS' Trauma Trial at July 2006 Meeting
HSMN NewsFeed - 26 May 2006
MultiCell Technologies Appoints Stephen Chang, Ph.D. as Chief Executive Officer
MultiCell Technologies Appoints Stephen Chang, Ph.D. as Chief Executive Officer
HSMN NewsFeed - 25 May 2006
Abraxis BioScience Bolsters Manufacturing and Global Operational Expertise With Key Senior Executives
Abraxis BioScience Bolsters Manufacturing and Global Operational Expertise With Key Senior Executives
HSMN NewsFeed - 25 May 2006
Thalomid(R) sNDA Granted FDA Approval For Treatment of Newly Diagnosed Multiple Myeloma
Thalomid(R) sNDA Granted FDA Approval For Treatment of Newly Diagnosed Multiple Myeloma
HSMN NewsFeed - 25 May 2006
Agile Therapeutics Closes $12 Million Financing for Development of a Low Estrogen Dose Contraceptive Patch
Agile Therapeutics Closes $12 Million Financing for Development of a Low Estrogen Dose Contraceptive Patch
HSMN NewsFeed - 25 May 2006
Significant ADHD Symptom Control With Shorter DAYTRANA(TM) (methylphenidate transdermal system) Wear Time
Significant ADHD Symptom Control With Shorter DAYTRANA(TM) (methylphenidate transdermal system) Wear Time
HSMN NewsFeed - 25 May 2006
Dr. Frank J. Bellizzi Appointed President of Zila's Pharmaceutical Division
Dr. Frank J. Bellizzi Appointed President of Zila's Pharmaceutical Division
HSMN NewsFeed - 25 May 2006
Antipodean Pharmaceuticals Initiates Phase 2 Trial in Parkinson's Disease
Antipodean Pharmaceuticals Initiates Phase 2 Trial in Parkinson's Disease
HSMN NewsFeed - 25 May 2006
Isotechnika signs agreement granting Lux Biosciences Worldwide Ophthalmic rights to ISA247
Isotechnika signs agreement granting Lux Biosciences Worldwide Ophthalmic rights to ISA247
HSMN NewsFeed - 25 May 2006
Dr. Gerard T. Kennealey Joins MGI PHARMA as Senior Vice President, Clinical Development
Dr. Gerard T. Kennealey Joins MGI PHARMA as Senior Vice President, Clinical Development
HSMN NewsFeed - 25 May 2006
Encysive Pharmaceuticals Submits Complete Response to FDA for Thelin(TM) New Drug Application
Encysive Pharmaceuticals Submits Complete Response to FDA for Thelin(TM) New Drug Application
HSMN NewsFeed - 25 May 2006
SciClone Reports Final Results From Second ZADAXIN U.S. Phase 3 Hepatitis C Trial
SciClone Reports Final Results From Second ZADAXIN U.S. Phase 3 Hepatitis C Trial
HSMN NewsFeed - 25 May 2006
UCB Sells to Adams Respiratory Therapeutics OTC Delsym(R) 12-Hour Cough Suppressant Liquids
UCB Sells to Adams Respiratory Therapeutics OTC Delsym(R) 12-Hour Cough Suppressant Liquids
HSMN NewsFeed - 24 May 2006
Valera Pharmaceuticals Appoints Jeremy D. Middleton To The Position Of Vice President, Business Development
Valera Pharmaceuticals Appoints Jeremy D. Middleton To The Position Of Vice President, Business Development
HSMN NewsFeed - 24 May 2006
ProMetic Life Sciences Inc. Provides Update on PPPS Licensing Agreement with Hemosol
ProMetic Life Sciences Inc. Provides Update on PPPS Licensing Agreement with Hemosol
HSMN NewsFeed - 24 May 2006
Ocera Therapeutics Initiates Phase 3 Trial in Fistulizing Crohn's Disease
Ocera Therapeutics Initiates Phase 3 Trial in Fistulizing Crohn's Disease
HSMN NewsFeed - 24 May 2006
Akorn, Inc. Announces Product Approval for Orphenadrine Citrate Injection
Akorn, Inc. Announces Product Approval for Orphenadrine Citrate Injection
HSMN NewsFeed - 24 May 2006
Onset Therapeutics Announces Launch of Optase(TM), a Novel Wound Care Product
Onset Therapeutics Announces Launch of Optase(TM), a Novel Wound Care Product
HSMN NewsFeed - 24 May 2006
OREXIGEN(TM) Therapeutics Appoints Graham Cooper as Chief Financial Officer
OREXIGEN(TM) Therapeutics Appoints Graham Cooper as Chief Financial Officer
HSMN NewsFeed - 24 May 2006
Dyax Announces the Appointment of Peggy Berry as Senior Vice President of Quality and Regulatory Affairs
Dyax Announces the Appointment of Peggy Berry as Senior Vice President of Quality and Regulatory Affairs
HSMN NewsFeed - 24 May 2006
GlaxoSmithKline Demonstrates Progress of Oncology Portfolio; New Data to Be Presented at ASCO 2006
GlaxoSmithKline Demonstrates Progress of Oncology Portfolio; New Data to Be Presented at ASCO 2006
HSMN NewsFeed - 23 May 2006
New Study Suggests Symbyax(R) Significantly Improves Symptoms of Treatment-Resistant Depression
New Study Suggests Symbyax(R) Significantly Improves Symptoms of Treatment-Resistant Depression
HSMN NewsFeed - 23 May 2006
CEL-SCI Presents Long-Term Survival Data With Its Anti-Cancer Drug Multikine(R)
CEL-SCI Presents Long-Term Survival Data With Its Anti-Cancer Drug Multikine(R)
HSMN NewsFeed - 23 May 2006
ALZA Corporation Receives FDA Approval for IONSYS(TM) (Fentanyl Iontophoretic Transdermal System)
ALZA Corporation Receives FDA Approval for IONSYS(TM) (Fentanyl Iontophoretic Transdermal System)
HSMN NewsFeed - 23 May 2006
AVANIR Announces the Intended Acquisition of a Private Specialty Pharmaceutical Company
AVANIR Announces the Intended Acquisition of a Private Specialty Pharmaceutical Company
HSMN NewsFeed - 23 May 2006
Schering-Plough Initiates PEG-INTRON 'PROTECT' Study in Liver Transplant Patients with Recurrent Hepatitis C
Schering-Plough Initiates PEG-INTRON 'PROTECT' Study in Liver Transplant Patients with Recurrent Hepatitis C
HSMN NewsFeed - 23 May 2006
Ventaira Announces Positive Scintigraphy Data with Next-Generation Pulmonary Drug Delivery Device
Ventaira Announces Positive Scintigraphy Data with Next-Generation Pulmonary Drug Delivery Device
HSMN NewsFeed - 23 May 2006
Halozyme Therapeutics Announces FDA 510(k) Clearance for MediCult's SynVitro Cumulase Product
Halozyme Therapeutics Announces FDA 510(k) Clearance for MediCult's SynVitro Cumulase Product
HSMN NewsFeed - 23 May 2006
Recruitment to Resume in Avastin International Phase III Trial (AVANT) in Early-Stage Colon Cancer
Recruitment to Resume in Avastin International Phase III Trial (AVANT) in Early-Stage Colon Cancer
HSMN NewsFeed - 23 May 2006
Recruitment Planned to Resume in AVANT International Phase III Trial in Adjuvant Colon Cancer
Recruitment Planned to Resume in AVANT International Phase III Trial in Adjuvant Colon Cancer
HSMN NewsFeed - 22 May 2006
New Studies Examine SEROQUEL(R) in Combination With Antidepressant Therapy in Patients With Depression
New Studies Examine SEROQUEL(R) in Combination With Antidepressant Therapy in Patients With Depression
HSMN NewsFeed - 22 May 2006
New Data Presented on the Effect of Cymbalta(R) on Sexual Function in Depressed Patients
New Data Presented on the Effect of Cymbalta(R) on Sexual Function in Depressed Patients
HSMN NewsFeed - 22 May 2006
Study Investigates NEXIUM(R) Benefits Patients With Zollinger-Ellison Syndrome
Study Investigates NEXIUM(R) Benefits Patients With Zollinger-Ellison Syndrome
HSMN NewsFeed - 22 May 2006
New Study Shows Erosive Esophagitis Healing Linked to Gastric Acid Control
New Study Shows Erosive Esophagitis Healing Linked to Gastric Acid Control
HSMN NewsFeed - 22 May 2006
Xanthus Pharmaceuticals Appoints John Lister-James, Ph.D. as Vice President, Development
Xanthus Pharmaceuticals Appoints John Lister-James, Ph.D. as Vice President, Development
HSMN NewsFeed - 22 May 2006
ProEthic Pharmaceuticals Initiates Pivotal Phase III Trial for Fast-Acting Migraine Product Candidate
ProEthic Pharmaceuticals Initiates Pivotal Phase III Trial for Fast-Acting Migraine Product Candidate
HSMN NewsFeed - 22 May 2006
Oscient Pharmaceuticals Hires Philippe M. Maitre as Senior Vice President and Chief Financial Officer
Oscient Pharmaceuticals Hires Philippe M. Maitre as Senior Vice President and Chief Financial Officer
HSMN NewsFeed - 22 May 2006
Corcept Therapeutics Completes Enrollment in Second Phase 3 Study for Treating Psychotic Major Depression
Corcept Therapeutics Completes Enrollment in Second Phase 3 Study for Treating Psychotic Major Depression
HSMN NewsFeed - 19 May 2006
Targacept Announces Positive Phase II Results for TC-1734 (AZD3480) in Memory Impaired Older Subjects
Targacept Announces Positive Phase II Results for TC-1734 (AZD3480) in Memory Impaired Older Subjects
HSMN NewsFeed - 19 May 2006
Synovics Pharmaceuticals, Inc. Announces a Key New Member Joins Management
Synovics Pharmaceuticals, Inc. Announces a Key New Member Joins Management
HSMN NewsFeed - 19 May 2006
AVONEX(R), the Most Prescribed Multiple Sclerosis Therapy Worldwide, Celebrates 10th Anniversary
AVONEX(R), the Most Prescribed Multiple Sclerosis Therapy Worldwide, Celebrates 10th Anniversary
HSMN NewsFeed - 19 May 2006
Novavax and Esprit Pharma to Co-develop Novel Medicine for Female Sexual Desire Disorder
Novavax and Esprit Pharma to Co-develop Novel Medicine for Female Sexual Desire Disorder
HSMN NewsFeed - 18 May 2006
Alfacell Corporation To Launch New Program to Explore Potential of ONCONASE(R) to Prevent Mesothelioma
Alfacell Corporation To Launch New Program to Explore Potential of ONCONASE(R) to Prevent Mesothelioma
HSMN NewsFeed - 18 May 2006
Geron Names Laurence Elias, M.D., Vice President, Oncology Clinical Development
Geron Names Laurence Elias, M.D., Vice President, Oncology Clinical Development
HSMN NewsFeed - 18 May 2006
Baxter and Jerini Advance Program to Develop Non-Intravenous Hemophilia Therapy
Baxter and Jerini Advance Program to Develop Non-Intravenous Hemophilia Therapy
HSMN NewsFeed - 17 May 2006
AZILECT(R) FDA Approval Brings New Hope to People Living With Parkinson's Disease
AZILECT(R) FDA Approval Brings New Hope to People Living With Parkinson's Disease
HSMN NewsFeed - 17 May 2006
TAXUS(R) coronary stent system cited by EuroIntervention for superiority in diabetic patients
TAXUS(R) coronary stent system cited by EuroIntervention for superiority in diabetic patients
HSMN NewsFeed - 17 May 2006
Teva Announces FDA Grants Approval of AZILECT(R) (Rasagiline) for Parkinson's Disease
Teva Announces FDA Grants Approval of AZILECT(R) (Rasagiline) for Parkinson's Disease
HSMN NewsFeed - 17 May 2006
Cabrellis Pharmaceuticals Corporation Announces Corporate Launch and Founding Management Team
Cabrellis Pharmaceuticals Corporation Announces Corporate Launch and Founding Management Team
HSMN NewsFeed - 17 May 2006
Neotropix Receives FDA Approval to Begin Clinical Trials With First Investigational Cancer Drug
Neotropix Receives FDA Approval to Begin Clinical Trials With First Investigational Cancer Drug
HSMN NewsFeed - 17 May 2006
Baxter Appoints John Greisch President of International; Treasurer Robert Davis Succeeds Greisch as CFO
Baxter Appoints John Greisch President of International; Treasurer Robert Davis Succeeds Greisch as CFO
HSMN NewsFeed - 17 May 2006
New Data Show COREG CR (TM) Reduced Blood Pressure in Patients With Essential Hypertension
New Data Show COREG CR (TM) Reduced Blood Pressure in Patients With Essential Hypertension
HSMN NewsFeed - 17 May 2006
Renovis Names Donald R. Joseph as Senior Vice President, Corporate Development and General Counsel
Renovis Names Donald R. Joseph as Senior Vice President, Corporate Development and General Counsel
HSMN NewsFeed - 17 May 2006
John Gutheil, M.D., Joins Proacta as Chief Medical Officer and Senior Vice President of Clinical Affairs
John Gutheil, M.D., Joins Proacta as Chief Medical Officer and Senior Vice President of Clinical Affairs
HSMN NewsFeed - 16 May 2006
ImClone Systems Names Elizabeth Yamashita Vice President, Regulatory CMC and Operations
ImClone Systems Names Elizabeth Yamashita Vice President, Regulatory CMC and Operations
HSMN NewsFeed - 16 May 2006
Nymox Reports Positive New Efficacy Data for Benign Prostatic Hyperplasia Drug
Nymox Reports Positive New Efficacy Data for Benign Prostatic Hyperplasia Drug
HSMN NewsFeed - 16 May 2006
Valeant Pharmaceuticals Receives FDA Marketing Approval for Cannabinoid Cesamet(TM) (CII)
Valeant Pharmaceuticals Receives FDA Marketing Approval for Cannabinoid Cesamet(TM) (CII)
HSMN NewsFeed - 16 May 2006
Genitope Corporation Appoints Dr. Mary Rybak Vice President of Medical Affairs
Genitope Corporation Appoints Dr. Mary Rybak Vice President of Medical Affairs
HSMN NewsFeed - 16 May 2006
Bioenvision and Mayne Pharma Announce Marketing and Distribution Agreement for Evoltra(R)
Bioenvision and Mayne Pharma Announce Marketing and Distribution Agreement for Evoltra(R)
HSMN NewsFeed - 16 May 2006
BioAlliance Pharma Boosts Business Development Operations in Europe and US
BioAlliance Pharma Boosts Business Development Operations in Europe and US
HSMN NewsFeed - 15 May 2006
Dusa Pharmaceuticals Announces Court Ruling Halts Sale of Generic Nicomide'R'
Dusa Pharmaceuticals Announces Court Ruling Halts Sale of Generic Nicomide'R'
HSMN NewsFeed - 15 May 2006
Advaxis Continues Advancement of Two Listeria Vaccines Targeting Cancers Affecting Women
Advaxis Continues Advancement of Two Listeria Vaccines Targeting Cancers Affecting Women
HSMN NewsFeed - 15 May 2006
Panacos Appoints Dr. Frederick Schmid Senior Vice President, Commercial Operations and Business Development
Panacos Appoints Dr. Frederick Schmid Senior Vice President, Commercial Operations and Business Development
HSMN NewsFeed - 15 May 2006
Mentor Begins U.S. Phase 1 Study of Its Botulinum Toxin Product for Spasmodic Torticollis/Cervical Dystonia
Mentor Begins U.S. Phase 1 Study of Its Botulinum Toxin Product for Spasmodic Torticollis/Cervical Dystonia
HSMN NewsFeed - 15 May 2006
Somaxon Pharmaceuticals Names Matthew Onaitis Vice President of Legal Affairs
Somaxon Pharmaceuticals Names Matthew Onaitis Vice President of Legal Affairs
HSMN NewsFeed - 15 May 2006
Clinical Data Announces Management Reorganization and Plan to Spin Off Vilazodone Business
Clinical Data Announces Management Reorganization and Plan to Spin Off Vilazodone Business
HSMN NewsFeed - 15 May 2006
Advancis Pharmaceutical Receives FDA Approval Letter for New Strengths of Keflex
Advancis Pharmaceutical Receives FDA Approval Letter for New Strengths of Keflex
HSMN NewsFeed - 15 May 2006
ESBATech AG Announces Appointment of James Egan as Chief Business Officer
ESBATech AG Announces Appointment of James Egan as Chief Business Officer
HSMN NewsFeed - 15 May 2006
EntreMed Initiates Combination Phase 2 Clinical Trial With Panzem(R) NCD in Carcinoid Cancer
EntreMed Initiates Combination Phase 2 Clinical Trial With Panzem(R) NCD in Carcinoid Cancer
HSMN NewsFeed - 12 May 2006
Acadesine Reduces Two-year Mortality Following Heart Attacks in Heart Bypass Patients
Acadesine Reduces Two-year Mortality Following Heart Attacks in Heart Bypass Patients
HSMN NewsFeed - 11 May 2006
PDI, Inc. Announces a Significant New Contract Sales Engagement With a Major Pharmaceutical Company
PDI, Inc. Announces a Significant New Contract Sales Engagement With a Major Pharmaceutical Company
HSMN NewsFeed - 11 May 2006
Genentech Announces Vice President Appointments in Commercial Operations and Product Development
Genentech Announces Vice President Appointments in Commercial Operations and Product Development
HSMN NewsFeed - 11 May 2006
ConjuChem Announces New Executive Vice President, Research and Development
ConjuChem Announces New Executive Vice President, Research and Development
HSMN NewsFeed - 11 May 2006
Merck Announces Preliminary Analyses of Off-Drug Extension of APPROVe Study
Merck Announces Preliminary Analyses of Off-Drug Extension of APPROVe Study
HSMN NewsFeed - 11 May 2006
FDA Grants Accentia Biopharmaceuticals, Inc.'s Majority-Owned Subsidiary Fast Track Status for BiovaxID(TM)
FDA Grants Accentia Biopharmaceuticals, Inc.'s Majority-Owned Subsidiary Fast Track Status for BiovaxID(TM)
HSMN NewsFeed - 11 May 2006
Pfizer's Smoking Cessation Medicine Chantix(TM) (Varenicline) Receives FDA Approval
Pfizer's Smoking Cessation Medicine Chantix(TM) (Varenicline) Receives FDA Approval
HSMN NewsFeed - 11 May 2006
Diatos Announces Acquisition of Specialty Cancer Product DaunoXome(R) from Gilead Sciences
Diatos Announces Acquisition of Specialty Cancer Product DaunoXome(R) from Gilead Sciences
HSMN NewsFeed - 10 May 2006
Axcan Pharma appoints new Senior Vice President and Chief Scientific Officer
Axcan Pharma appoints new Senior Vice President and Chief Scientific Officer
HSMN NewsFeed - 10 May 2006
Proteon Therapeutics Hires Veteran Biotechnology Executive Timothy Noyes as CEO
Proteon Therapeutics Hires Veteran Biotechnology Executive Timothy Noyes as CEO
HSMN NewsFeed - 10 May 2006
Novo Nordisk Appoints Edward Williams as Vice President of Biopharmaceuticals
Novo Nordisk Appoints Edward Williams as Vice President of Biopharmaceuticals
HSMN NewsFeed - 10 May 2006
Depomed Finalizes Phase III Clinical Trial Protocol for Gabapentin GR(TM)
Depomed Finalizes Phase III Clinical Trial Protocol for Gabapentin GR(TM)
HSMN NewsFeed - 10 May 2006
Unigene Enters into Exclusive Distribution Agreement for Fortical(R) Nasal Spray in Israel
Unigene Enters into Exclusive Distribution Agreement for Fortical(R) Nasal Spray in Israel
HSMN NewsFeed - 10 May 2006
NephroGenex Licenses Pyridorin(TM) for Diabetic Nephropathy and Acute Renal Failure
NephroGenex Licenses Pyridorin(TM) for Diabetic Nephropathy and Acute Renal Failure
HSMN NewsFeed - 10 May 2006
VIVUS Announces Positive Phase 2 Clinical Trial Results With Qnexa, a Novel Therapy to Treat Obesity
VIVUS Announces Positive Phase 2 Clinical Trial Results With Qnexa, a Novel Therapy to Treat Obesity
HSMN NewsFeed - 10 May 2006
UCB and Immunomedics announce worldwide development collaboration and license agreement for Epratuzumab
UCB and Immunomedics announce worldwide development collaboration and license agreement for Epratuzumab
HSMN NewsFeed - 10 May 2006
Immunomedics and UCB Announce Worldwide Development Collaboration and License Agreement for Epratuzumab
Immunomedics and UCB Announce Worldwide Development Collaboration and License Agreement for Epratuzumab
HSMN NewsFeed - 9 May 2006
ITC Accepts Amgen's Complaint to Investigate Roche's Importation of Peg-EPO
ITC Accepts Amgen's Complaint to Investigate Roche's Importation of Peg-EPO
HSMN NewsFeed - 9 May 2006
Baxter Receives FDA Approval for Ultra-High Dosage Strength of ADVATE for Hemophilia A
Baxter Receives FDA Approval for Ultra-High Dosage Strength of ADVATE for Hemophilia A
HSMN NewsFeed - 9 May 2006
Lilly Submits Cymbalta(R) Supplemental New Drug Application for Generalized Anxiety Disorder
Lilly Submits Cymbalta(R) Supplemental New Drug Application for Generalized Anxiety Disorder
HSMN NewsFeed - 9 May 2006
Aradigm Receives FDA Orphan Drug Designation of Liposomal Ciprofloxacin for Cystic Fibrosis
Aradigm Receives FDA Orphan Drug Designation of Liposomal Ciprofloxacin for Cystic Fibrosis
HSMN NewsFeed - 9 May 2006
Gendux AB and Introgen Therapeutics File European Orphan Drug Designation for ADVEXIN
Gendux AB and Introgen Therapeutics File European Orphan Drug Designation for ADVEXIN
HSMN NewsFeed - 9 May 2006
Labopharm Enters Into Distribution Agreement with Grunenthal for Once-Daily Tramadol in Belgium
Labopharm Enters Into Distribution Agreement with Grunenthal for Once-Daily Tramadol in Belgium
HSMN NewsFeed - 9 May 2006
Maxygen Achieves Milestone in Alliance with Roche for Factor VIIa Therapeutics
Maxygen Achieves Milestone in Alliance with Roche for Factor VIIa Therapeutics
HSMN NewsFeed - 9 May 2006
Angina Patients Cost Managed Care Over Twice as Much as Coronary Artery Disease Patients Without Angina
Angina Patients Cost Managed Care Over Twice as Much as Coronary Artery Disease Patients Without Angina
HSMN NewsFeed - 8 May 2006
Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP -- Extended Release Tablets
Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP -- Extended Release Tablets
HSMN NewsFeed - 8 May 2006
Connetics Names Sunil Patel Vice President, Corporate Development and Strategy
Connetics Names Sunil Patel Vice President, Corporate Development and Strategy
HSMN NewsFeed - 8 May 2006
Introgen's ADVEXIN p53 Therapy Provided to Cancer Patients With Li-Fraumeni Syndrome
Introgen's ADVEXIN p53 Therapy Provided to Cancer Patients With Li-Fraumeni Syndrome
HSMN NewsFeed - 8 May 2006
Accentia Biopharmaceuticals Receives FDA Approval for Three Unique Dosage Combination Pain Product ANDAs
Accentia Biopharmaceuticals Receives FDA Approval for Three Unique Dosage Combination Pain Product ANDAs
HSMN NewsFeed - 8 May 2006
Thermo Electron and Fisher Scientific to Combine in Industry-Transforming Transaction
Thermo Electron and Fisher Scientific to Combine in Industry-Transforming Transaction
HSMN NewsFeed - 8 May 2006
Mission Pharmacal Completes Phase III Study of Tindamax(R) for the Treatment of Bacterial Vaginosis
Mission Pharmacal Completes Phase III Study of Tindamax(R) for the Treatment of Bacterial Vaginosis
HSMN NewsFeed - 8 May 2006
Athenagen Announces the Appointment of John Donovan as Chief Financial Officer
Athenagen Announces the Appointment of John Donovan as Chief Financial Officer
HSMN NewsFeed - 8 May 2006
Endovasc Announces Agreement with PYRAMID Labs to Manufacture Liprostin for Phase IIIa Trial
Endovasc Announces Agreement with PYRAMID Labs to Manufacture Liprostin for Phase IIIa Trial
HSMN NewsFeed - 8 May 2006
Pfizer and Monogram to Make HIV Co-Receptor Tropism Assay Available Globally
Pfizer and Monogram to Make HIV Co-Receptor Tropism Assay Available Globally
HSMN NewsFeed - 8 May 2006
Cadence Pharmaceuticals Announces Additions to Senior Management and Board of Directors
Cadence Pharmaceuticals Announces Additions to Senior Management and Board of Directors
HSMN NewsFeed - 8 May 2006
PDI Announces Appointment of Michael J. Marquard as Chief Executive Officer
PDI Announces Appointment of Michael J. Marquard as Chief Executive Officer
HSMN NewsFeed - 8 May 2006
Hana Biosciences Completes Licensing of Three Targeted Cancer Drug Candidates from Inex Pharmaceuticals
Hana Biosciences Completes Licensing of Three Targeted Cancer Drug Candidates from Inex Pharmaceuticals
HSMN NewsFeed - 8 May 2006
Frova(R) Meets Primary Endpoint in Second Phase III Study for Prevention of Menstrual Migraine
Frova(R) Meets Primary Endpoint in Second Phase III Study for Prevention of Menstrual Migraine
HSMN NewsFeed - 5 May 2006
Janssen-Cilag Submits Marketing Authorization Application in Europe for New Treatment for Schizophrenia
Janssen-Cilag Submits Marketing Authorization Application in Europe for New Treatment for Schizophrenia
HSMN NewsFeed - 5 May 2006
ORADUR(TM) Technology Milestone: Remoxy(TM) (ORADUR-Based Oxycodone) Commences Pivotal Phase III Program
ORADUR(TM) Technology Milestone: Remoxy(TM) (ORADUR-Based Oxycodone) Commences Pivotal Phase III Program
HSMN NewsFeed - 5 May 2006
MIV Therapeutics Establishes U.S. Corporate Headquarters with Opening of New Offices in Atlanta, GA
MIV Therapeutics Establishes U.S. Corporate Headquarters with Opening of New Offices in Atlanta, GA
HSMN NewsFeed - 4 May 2006
ImmunoGen, Inc. to Develop Commercial-Scale Manufacturing Process for Trastuzumab-DM1 for Genentech
ImmunoGen, Inc. to Develop Commercial-Scale Manufacturing Process for Trastuzumab-DM1 for Genentech
HSMN NewsFeed - 4 May 2006
Jury Rules in Favor of ARIAD and Co-Plaintiffs in Lilly NF-(kappa)B Patent Infringement Lawsuit
Jury Rules in Favor of ARIAD and Co-Plaintiffs in Lilly NF-(kappa)B Patent Infringement Lawsuit
HSMN NewsFeed - 4 May 2006
GlaxoSmithKline and Adolor Present Positive Results from a Clinical Study of Alvimopan (Entereg(R))
GlaxoSmithKline and Adolor Present Positive Results from a Clinical Study of Alvimopan (Entereg(R))
